Journal of the Pediatric Infectious Diseases Society and the Journal of Infectious Diseases Collaboration: The First Fruits From a New Tree - Scorecard - MDSpire

Journal of the Pediatric Infectious Diseases Society and the Journal of Infectious Diseases Collaboration: The First Fruits From a New Tree

  • By

  • Ravi Jhaveri

  • Cynthia L Sears

  • February 10, 2025

  • 0 min

Share

Clinical Scorecard: Collaboration Between the Journal of Pediatric Infectious Diseases and the Journal of Infectious Diseases: Initial Outcomes from a New Partnership

At a Glance

CategoryDetail
ConditionCentral Nervous System (CNS) infections caused by various pathogens
Key MechanismsPathogen ability to overcome host anatomic and immunologic defenses; host–pathogen interactions influenced by developmental and maturational factors
Target PopulationBoth pediatric and adult patients with CNS infections
Care SettingInfectious disease specialty care, including clinical and research settings

Key Highlights

  • Journals JID and JPIDS have initiated a collaborative series focusing on neurovirulence in CNS infections.
  • The series covers diverse pathogens including viruses, bacteria, fungi, and parasites affecting CNS.
  • Differences in pathogenesis between children and adults provide insights into host–pathogen interactions.

Guideline-Based Recommendations

Diagnosis

  • Consider developmental and maturational factors when evaluating CNS infections in different age groups.
  • Utilize multidisciplinary approaches integrating basic science and clinical insights for diagnosis.

Management

  • Tailor management strategies recognizing similarities and differences in CNS infection pathogenesis between children and adults.

Monitoring & Follow-up

  • Monitor clinical manifestations with attention to age-specific host responses.

Risks

  • Recognize that pathogen-specific neurovirulence mechanisms vary and impact disease progression.

Patient & Prescribing Data

Pediatric and adult patients with CNS infections caused by pathogens such as Zika, cytomegalovirus, herpes simplex virus, group B streptococci, and others.

Treatment approaches should consider pathogen-specific features and host developmental status; collaboration between pediatric and adult infectious disease expertise enhances care.

Clinical Best Practices

  • Foster interdisciplinary collaboration across pediatric and adult infectious disease specialties.
  • Incorporate insights from basic science and translational research into clinical practice.
  • Engage in ongoing education and review of emerging literature on neurovirulence and CNS infections.

References

Original Source(s)

Related Content